Inbound Trade Mission Programme | Get ready to boost your business
Posted:
Get ready to boost your business with GIANT Health this year.
Gain the most powerful opportunity to drive your company to a higher level of success. Join us and purchase a suitable package at a lower cost now.
Kisqali, a key targeted therapy for breast cancer from Novartis, until now has been indicated only for patients with metastatic disease. But, the Food and Drug Administration approved Kisqali in combination with hormone therapy for patients with certain early-stage breast cancers. …
Wearable technology that monitors our bodies can be helpful and harmful.
Wearable technology affords the opportunity to check, re-check, and check again, leading to fixation.
Read the full article in the Psychology Today blog post here.